том 6 издание 6 страницы 1049-1066

Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases

Тип публикацииJournal Article
Дата публикации2011-04-19
scimago Q1
wos Q2
БС2
SJR0.717
CiteScore6.7
Impact factor3.4
ISSN18607179, 18607187
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
General Pharmacology, Toxicology and Pharmaceutics
Краткое описание
The prevention of blood coagulation is important in treating thromboembolic disorders, and several serine proteases involved in the coagulation cascade have been classified as pharmaceutically relevant. Whereas structure‐based drug design has contributed to the development of some serine protease inhibitors, traditional computational methods have not been able to fully describe structure–activity relationships (SAR). Here, we study the SAR for a number of serine proteases by using a method that calculates the thermodynamic properties (enthalpy and entropy) of the water that solvates the active site. We show that the displacement of water from specific subpockets (such as S1–4 and the ester binding pocket) of the active site by the ligand can govern potency, especially for cases in which small chemical changes (i.e., a methyl group or halogen) result in a substantial increase in potency. Furthermore, we describe how relative binding free energies can be estimated by combining the water displacement energy with complementary terms from an implicit solvent molecular mechanics description binding.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

5
10
15
20
25
Journal of Chemical Information and Modeling
24 публикации, 21.05%
Journal of Chemical Theory and Computation
8 публикаций, 7.02%
Journal of Medicinal Chemistry
6 публикаций, 5.26%
Journal of Physical Chemistry B
5 публикаций, 4.39%
Journal of Computer-Aided Molecular Design
4 публикации, 3.51%
Bioorganic and Medicinal Chemistry Letters
3 публикации, 2.63%
Proteins: Structure, Function and Genetics
3 публикации, 2.63%
Journal of Biomolecular Structure and Dynamics
3 публикации, 2.63%
Nature Communications
2 публикации, 1.75%
Communications Chemistry
2 публикации, 1.75%
Drug Discovery Today
2 публикации, 1.75%
ChemistrySelect
2 публикации, 1.75%
ChemMedChem
2 публикации, 1.75%
Journal of the American Chemical Society
2 публикации, 1.75%
Biochemistry
2 публикации, 1.75%
Expert Opinion on Drug Discovery
2 публикации, 1.75%
Proceedings of the National Academy of Sciences of the United States of America
2 публикации, 1.75%
Lipophilicity in Drug Action and Toxicology
2 публикации, 1.75%
Mendeleev Communications
1 публикация, 0.88%
Journal of Chemical Physics
1 публикация, 0.88%
Current Medicinal Chemistry
1 публикация, 0.88%
Future Medicinal Chemistry
1 публикация, 0.88%
Toxins
1 публикация, 0.88%
Frontiers in Chemistry
1 публикация, 0.88%
European Physical Journal: Special Topics
1 публикация, 0.88%
In Silico Pharmacology
1 публикация, 0.88%
Journal of Cheminformatics
1 публикация, 0.88%
Journal of Molecular Modeling
1 публикация, 0.88%
Nature Reviews Drug Discovery
1 публикация, 0.88%
5
10
15
20
25

Издатели

10
20
30
40
50
American Chemical Society (ACS)
50 публикаций, 43.86%
Wiley
16 публикаций, 14.04%
Elsevier
15 публикаций, 13.16%
Springer Nature
14 публикаций, 12.28%
Taylor & Francis
6 публикаций, 5.26%
Proceedings of the National Academy of Sciences (PNAS)
2 публикации, 1.75%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 0.88%
AIP Publishing
1 публикация, 0.88%
Bentham Science Publishers Ltd.
1 публикация, 0.88%
MDPI
1 публикация, 0.88%
Frontiers Media S.A.
1 публикация, 0.88%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 0.88%
Public Library of Science (PLoS)
1 публикация, 0.88%
Royal Society of Chemistry (RSC)
1 публикация, 0.88%
Cold Spring Harbor Laboratory
1 публикация, 0.88%
10
20
30
40
50
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
114
Поделиться
Цитировать
ГОСТ |
Цитировать
ABEL R. et al. Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases // ChemMedChem. 2011. Vol. 6. No. 6. pp. 1049-1066.
ГОСТ со всеми авторами (до 50) Скопировать
ABEL R., Salam N. K., Shelley J., Farid R., Friesner R. A., Sherman W. Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases // ChemMedChem. 2011. Vol. 6. No. 6. pp. 1049-1066.
RIS |
Цитировать
TY - JOUR
DO - 10.1002/cmdc.201000533
UR - https://doi.org/10.1002/cmdc.201000533
TI - Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases
T2 - ChemMedChem
AU - ABEL, ROBERT R.
AU - Salam, Noeris K
AU - Shelley, John
AU - Farid, Ramy
AU - Friesner, Richard A.
AU - Sherman, Woody
PY - 2011
DA - 2011/04/19
PB - Wiley
SP - 1049-1066
IS - 6
VL - 6
PMID - 21506273
SN - 1860-7179
SN - 1860-7187
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2011_ABEL,
author = {ROBERT R. ABEL and Noeris K Salam and John Shelley and Ramy Farid and Richard A. Friesner and Woody Sherman},
title = {Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases},
journal = {ChemMedChem},
year = {2011},
volume = {6},
publisher = {Wiley},
month = {apr},
url = {https://doi.org/10.1002/cmdc.201000533},
number = {6},
pages = {1049--1066},
doi = {10.1002/cmdc.201000533}
}
MLA
Цитировать
ABEL, ROBERT R., et al. “Contribution of Explicit Solvent Effects to the Binding Affinity of Small‐Molecule Inhibitors in Blood Coagulation Factor Serine Proteases.” ChemMedChem, vol. 6, no. 6, Apr. 2011, pp. 1049-1066. https://doi.org/10.1002/cmdc.201000533.